Recombinant Human HPGDS Protein, CF Summary
Details of Functionality |
Measured by the conjugation of reduced glutathione to 1-bromo-2,4-dinitrobenzene. The specific activity is >650 pmol/min/μg, as measured under the described conditions. |
Source |
E. coli-derived human Hematopoietic Prostaglandin D Synthase/HPGDS protein Met1-Leu199, with a C-terminal 6-His tag |
Accession # |
|
N-terminal Sequence |
Pro2 |
Protein/Peptide Type |
Recombinant Enzymes |
Gene |
HPGDS |
Purity |
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane |
Endotoxin Note |
<1.0 EU per 1 μg of the protein by the LAL method. |
Applications/Dilutions
Dilutions |
|
Theoretical MW |
24 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
SDS-PAGE |
24-26 kDa, reducing conditions |
Packaging, Storage & Formulations
Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 6 months from date of receipt, -70 °C as supplied.
- 3 months, -70 °C under sterile conditions after opening.
|
Buffer |
Supplied as a 0.2 μm filtered solution in Tris and NaCl. |
Purity |
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane |
Assay Procedure |
- Assay Buffer: 100 mM NaH2PO4, pH 7.0
- Recombinant Human Hematopoietic Prostaglandin D Synthase/HPGDS (rhHPGDS) (Catalog # 6487-PS)
- Substrate: 1-bromo-2,4-dinitrobenzene (BDNB) (Sigma, Catalog # 262226), 75 mM stock in ethanol
- L-Glutathione, reduced (GSH) (Amresco, Catalog # 399), 250 mM stock in deionized water
- UV Plate (Costar, Catalog # 3635)
- Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
- Dilute rhHPGDS to 40 ng/μL in Assay Buffer.
- Dilute the GSH to 4 mM in Assay Buffer.
- Combine equal volumes of 40 ng/μL rhHPGDS and 4 mM GSH for 20 ng/μL rhHPGDS with 2 mM GSH.
- Dilute Substrate to 2 mM in Assay Buffer.
- Load into a UV plate 50 μL of the 20 ng/μL rhHPGDS with 2 mM GSH mixture. Include a substrate blank containing 25 μL of Assay Buffer with 25 μL of the 4 mM GSH prepared in step 2.
- Start the reaction by adding 50 μL of 2 mM Substrate to wells.
- Read in kinetic mode for 5 minutes at an absorbance of 340 nm.
- Calculate specific activity:
Specific Activity (pmol/min/µg) = |
Adjusted Vmax* (OD/min) x well volume (L) x 1012 pmol/mol |
ext. coeff** (M-1cm-1) x path corr.*** (cm) x amount of enzyme (µg) | *Adjusted for Substrate Blank **Using the extinction coefficient 9600 M -1cm -1 ***Using the path correction 0.320 cm Note: the output of many spectrophotometers is in mOD. Per Well:
- rhHPGDS: 1 μg
- GSH: 1 mM
- Substrate: 1 mM
|
Notes
Coomassie is a registered trademark of Imperial Chemical Industries Ltd.
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human HPGDS Protein, CF
Background
Prostaglandin D Synthase (PGDS) catalyzes the conversion of prostaglandin (PG) H2 to PGD2, which is a major prostanoid produced in a variety of tissues. Two types of PGDS have been isolated; the glutathione-dependent hematopoietic PGDS (HPGDS) and the glutathione-independent lipocalin‑type PGDS (1). HPGDS is a cytosolic enzyme that is expressed in mast cells and antigen presenting cells (2, 3). It is the only mammalian member of the class Sigma glutathione S‑transferase, showing a broad specificity towards standard transferase substrates (4). The PGD2 produced by HPGDS is involved in many physiological processes such as maintaining body temperature, promotion of sleep, inhibition of platelet aggregation and bronchoconstriction (5). It also functions in immune response and acts as a mediator in allergy and inflammation (6). HPGDS‑specific inhibitors may be therapeutically useful anti‑allergic and anti‑inflammatory drugs.
- Urade, Y. and Eguchi, N. (2002) Prostaglandins Other Lipid Mediat. 68:375.
- Urade, Y. et al. (1990) J. Biol. Chem. 265:371.
- Urade, Y. et al. (1989) J. Immunol. 143:2982.
- Jowsey, I. R. et al. (2001) Biochem. J. 359:507.
- Kanaoka, Y. and Urade, Y. (2003) Prostaglandins Leukot. Essent. Fatty Acids 69:163.
- Oguma, T. et al. (2008) Allergol. Int. 57:307.
Customers Who Viewed This Item Also Viewed...
Species: Hu, Mu, Sh
Applications: Flow, ICC/IF, IHC, IHC-Fr, PEP-ELISA, WB
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
Species: Hu
Applications: Flow, ICC/IF, WB
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, Simple Western, WB
Species: Hu, Mu
Applications: ICC/IF, IHC, IHC-P, WB
Species: Hu, Mu, Rt
Applications: IHC, IHC-Fr, IHC-P, IP, WB
Species: Hu
Applications: ICC/IF, WB
Species: Hu
Applications: ICC/IF, IHC, IHC-P, WB
Species: Hu
Applications: ICC/IF, IHC, IHC-P
Species: Hu, Rt
Applications: IHC, IHC-Fr, IHC-P, Simple Western, WB
Species: Hu, Mu, Rt
Applications: ELISA, ICC/IF, WB
Species: Hu, Mu
Applications: IHC, IHC-P, WB
Species: Hu, Mu
Applications: IHC, IHC-P, WB
Species: Hu, Pm, Rt
Applications: ELISA, IHC, IHC-P, IP, WB
Species: Gp, Hu, Mu, Rt
Applications: ELISA, ICC/IF, IHC, IHC-P, WB
Species: Ca, Hu
Applications: ICC/IF, IHC, IHC-P
Publications for Hematopoietic Prostaglandin D Synthase/HPGDS (6487-PS) (0)
There are no publications for Hematopoietic Prostaglandin D Synthase/HPGDS (6487-PS).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for Hematopoietic Prostaglandin D Synthase/HPGDS (6487-PS) (0)
There are no reviews for Hematopoietic Prostaglandin D Synthase/HPGDS (6487-PS).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
FAQs for Hematopoietic Prostaglandin D Synthase/HPGDS (6487-PS) (0)
Additional Hematopoietic Prostaglandin D Synthase/HPGDS Products
Blogs on Hematopoietic Prostaglandin D Synthase/HPGDS